Synonyms: | |
Status: | Phase 3 |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | L01EK02 |
UNII: | NQU9IPY4K9 |
InChI Key | XXJWYDDUDKYVKI-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C25H27FN4O3 |
Molecular Weight | 450.51 |
AlogP | 5.22 |
Hydrogen Bond Acceptor | 6.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 8.0 |
Polar Surface Area | 72.5 |
Molecular species | BASE |
Aromatic Rings | 4.0 |
Heavy Atoms | 33.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Platelet-derived growth factor receptor inhibitor | PubMed |
Primary Target | |
---|---|
fms related receptor tyrosine kinase 1 | |
fms related receptor tyrosine kinase 4 | |
kinase insert domain receptor | |
KIT proto-oncogene, receptor tyrosine kinase | |
platelet derived growth factor receptor alpha | |
platelet derived growth factor receptor beta |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Glioblastoma | 3 | D005909 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Neoplasms | 3 | D009369 | ClinicalTrials |
Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Sarcoma, Alveolar Soft Part | 2 | D018234 | ClinicalTrials |
Colorectal Neoplasms | 2 | D015179 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
Breast Neoplasms | 2 | D001943 | ClinicalTrials |
Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
Uterine Cervical Neoplasms | 2 | D002583 | ClinicalTrials |
Brain Neoplasms | 1 | D001932 | ClinicalTrials |
Rectal Neoplasms | 1 | D012004 | ClinicalTrials |
Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
Leukemia | 1 | D007938 | ClinicalTrials |
Prostatic Neoplasms | 1 | D011471 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Melanoma | 1 | D008545 | ClinicalTrials |
Neoplasm Metastasis | 1 | D009362 | ClinicalTrials |
Thyroid Neoplasms | 1 | D013964 | ClinicalTrials |
Stomach Neoplasms | 1 | D013274 | ClinicalTrials |
Peritoneal Neoplasms | 1 | D010534 | ClinicalTrials |
Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
Lung Neoplasms | 1 | D008175 | ClinicalTrials |
Endometrial Neoplasms | 1 | D016889 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 288383-20-0 |
ChEBI | 94782 |
ChEMBL | CHEMBL491473 |
DrugBank | DB04849 |
EPA CompTox | DTXSID10183035 |
FDA SRS | NQU9IPY4K9 |
Guide to Pharmacology | 5664 |
PubChem | 9933475 |
SureChEMBL | SCHEMBL63147 |
ZINC | ZINC000003948085 |